From gut inflammation to gastrointestinal disorders current update on pathophysiology, molecular mechanism and pharmacological treatment modalities

Current Pharmaceutical Design

Volumn 20, Issue 7, 2014, Pages 1039-

  Sikiric, Predrag ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG EFFECTS; GASTRITIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMAN; PATHOPHYSIOLOGY;

GASTRITIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS;

EID: 84895104855     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161282007140221100428     Document Type: Editorial

References (11)

1. Ahluwalia A, Jones MK, Matysiak-Budnik T, Tarnawski AS. VEGF and colon cancer growth beyond angiogenesis: Does VEGF directly mediate colon cancer growth via a non-angiogenic mechanism? Curr Pharm Des 2014; 20(7): 1041-4.
2. Filaretova L, Podvigina T, Bagaeva T, Morozova O. From gastroprotective to ulcerogenic effects of glucocorticoids: role of long-term glucocorticoid action. Curr Pharm Des 2014; 20(7): 1045-50.
3. Guo ZZ, Wang P, Yi ZH, Huang ZY, Tang CW. The crosstalk between gut inflammation and gastrointestinal disorders during acute pancreatitis. Curr Pharm Des 2014; 20(7): 1051-62.
4. Gyires K, TÛth VE, Zdori ZS. Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalities. Curr Pharm Des 2014; 20(7): 1063-81.
5. Ko JK, Auyeung KK. Inflammatory bowel disease: etiology, pathogenesis and current therapy. Curr Pharm Des 2014; 20(7): 1082-96.
6. Nakamura M, Takahashi T, Matsui H, et al. New pharmaceutical treatment of gastric MALT Lymphoma: anti-angiogenesis treatment using VEGF receptor antibodies and celecoxib. Curr Pharm Des 2014; 20(7): 1097-1103.
7. Rakonczay Jr Z, Vg J, Fldes A, et al. Chronic inflammation in the pancreas and salivary glands lessons from similarities and differences in pathophysiology and treatment modalities. Curr Pharm Des 2014; 20(7): 1104-20.
8. Seiewerth S, Brcic L, Batelja Vuletic L, et al. BPC 157 and blood vessels. Curr Pharm Des 2014; 20(7): 1121-5.
9. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des 2014; 20(7): 1126-35.
10. Skroza N, Proietti I, Bernardini N, et al. Skin manifestations in course of celiac disease: literature review and case report. Curr Pharm Des 2014; 20(7): 1136-8.
11. Takeuchi K, Izuhara C, Takayama S, et al. Animal models of gastric bleeding induced by dual antiplatelet therapy using aspirin and clopidogrel. CurrPharm Des 2014; 20(7): 1139-48.